MNOVMediciNova, Inc.

$69M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$403,263

Balance Sheet

Total Assets

$71M

Total Liabilities

$3M

Stockholders' Equity

$68M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$3M	+13.1%
Net Income	-$3M	-$3M	+13.8%

MNOV Q1 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena